These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride]. Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048 [No Abstract] [Full Text] [Related]
3. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies. Cressman MD; Vidt DG; Gifford RW; Moore WS; Wilson DJ Am Heart J; 1984 May; 107(5 Pt 1):980-5. PubMed ID: 6720529 [TBL] [Abstract][Full Text] [Related]
4. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)]. Holzer H; Pogglitsch H; Katschnig H; Korthals C Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657 [TBL] [Abstract][Full Text] [Related]
5. The effect of labetalol in the treatment of severe drug-resistant hypertension. Morgan T; Gillies A; Morgan G; Adam W Med J Aust; 1978 Apr; 1(7):393-6. PubMed ID: 672730 [TBL] [Abstract][Full Text] [Related]
18. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension. Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627 [TBL] [Abstract][Full Text] [Related]
19. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient]. Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of hypertension by labetalol (author's transl)]. Sternon J; Melot C; Contu E Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430 [No Abstract] [Full Text] [Related] [Next] [New Search]